PMID- 10076897 OWN - NLM STAT- MEDLINE DCOM- 19990517 LR - 20190701 IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 260 IP - 3 DP - 1999 Feb 5 TI - A novel missense mutant inactivates GTP cyclohydrolase I in dopa-responsive dystonia. PG - 181-4 AB - Dopa-responsive dystonia (DRD) due to mutant GTP cyclohydrolase I (GCH) shows the considerable heterogeneity of clinical phenotypic expression. To explain the clinical diversity, we studied a Japanese family with a novel mutant GCH (GCH-G90V), where an affected heterozygote had a higher mutant/normal mRNA ratio than an unaffected heterozygote. Coexpression experiments using the mutant with wild-type GCH showed that GCH-G90V inactivated the normal enzyme in a dose-dependent manner, suggesting that the dominant negative effect of a mutant GCH on the normal enzyme might be one of the molecular mechanisms for the clinical heterogeneity of DRD. FAU - Hirano, M AU - Hirano M AD - Department of Medical Genetics, Nara Medical University, Kashihara, Japan. FAU - Komure, O AU - Komure O FAU - Ueno, S AU - Ueno S LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Dopamine Agents) RN - 0 (Isoenzymes) RN - 0 (RNA, Messenger) RN - 63-84-3 (Dihydroxyphenylalanine) RN - EC 3.5.4.16 (GTP Cyclohydrolase) SB - IM MH - Adult MH - Dihydroxyphenylalanine/*pharmacology MH - Dopamine Agents/*pharmacology MH - Dose-Response Relationship, Drug MH - Dystonia/drug therapy/*enzymology/*genetics MH - Female MH - GTP Cyclohydrolase/*genetics MH - Humans MH - Isoenzymes/genetics MH - Mutation, Missense/*physiology MH - Phenotype MH - Plasmids/genetics MH - RNA, Messenger/biosynthesis MH - Reverse Transcriptase Polymerase Chain Reaction EDAT- 1999/03/17 00:00 MHDA- 1999/03/17 00:01 CRDT- 1999/03/17 00:00 PHST- 1999/03/17 00:00 [pubmed] PHST- 1999/03/17 00:01 [medline] PHST- 1999/03/17 00:00 [entrez] AID - S0304394098009847 [pii] AID - 10.1016/s0304-3940(98)00984-7 [doi] PST - ppublish SO - Neurosci Lett. 1999 Feb 5;260(3):181-4. doi: 10.1016/s0304-3940(98)00984-7.